# René Bernards

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rene-bernards/

## Facts

| Field | Value |
| --- | --- |
| Citations | 79,301 |
| Field | Melanoma and MAPK Pathways |
| h-index | 113 |
| i10-index | 309 |
| Last Known Institution | The Netherlands Cancer Institute |
| OpenAlex ID | https://openalex.org/A5028266055 |
| ORCID iD | https://orcid.org/0000-0001-8677-3423 |
| Works | 908 |

## Researcher papers

- [70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer](https://scholariq.org/papers/70-gene-signature-as-an-aid-to-treatment-decisions-in-early-stage-breast-cancer/)
- [Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma](https://scholariq.org/papers/reversible-and-adaptive-resistance-to-braf-v600e-inhibition-in-melanoma/)
- [EGFR activation limits the response of liver cancer to lenvatinib](https://scholariq.org/papers/egfr-activation-limits-the-response-of-liver-cancer-to-lenvatinib/)
- [MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling](https://scholariq.org/papers/med12-controls-the-response-to-multiple-cancer-drugs-through-regulation-of-tgf/)
- [Reduced <i>NF1</i> Expression Confers Resistance to EGFR Inhibition in Lung Cancer](https://scholariq.org/papers/reduced-i-nf1-i-expression-confers-resistance-to-egfr-inhibition-in-lung-cancer/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Researcher university

- [The Netherlands Cancer Institute](https://scholariq.org/institutions/the-netherlands-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.